From Nanoparticles to Neurotech: Tetiana Aleksandrova on Subsense

A non-surgical brain–computer interface built with nanoparticles. Tetiana Aleksandrova, Founder & CEO of Subsense, shares how her team is aiming for invasive-level accuracy without surgery and why she believes BCIs will become one of the biggest technology revolutions of our lifetime.

Read More

From Lab to Clinic: How NeuroBionics Is Redefining Neuromodulation

From lab to clinic, NeuroBionics is redefining neuromodulation with flexible, vascular‑based neural interfaces. In this interview, co‑founder Nicolette Driscoll shares her journey, the technical breakthroughs behind their evStim device, and how they’re pushing neurotechnology forward.

Read More

Building the Matrix for Neurotech: Sam Hosovsky on the Future of Brain-Computer Interfaces

Sam Hosovsky, CEO of uCat, shares his journey into neurotechnology and how his company is transforming brain-computer interface (BCI) development through VR-based training and avatar embodiment. Discover how uCat is helping redefine clinical adoption of BCIs.

Read More